Cytokinetics News

News on Cytokinetics (Ticker: CYTK) continually updated from thousands of sources around the net.

Thursday May 24 | Freshnews

Cytokinetics Announces Opening of Second Cohort in Phase IIb Clinical ...

Cytokinetics Announces Opening of Second Cohort in Phase IIb Clinical Trial of Intravenous Omecamtiv Mecarbil in Patients With Acute Heart Failure Cytokinetics, Incorporated announced today the opening to enrollment of the second cohort in the ongoing, international, randomized, double-blind, placebo-controlled Phase IIb clinical trial of an ... (more)

Comment?

Related Topix: Startups

Tue May 15, 2012

Freshnews

Cytokinetics to Hold Annual Meeting of Stockholders

Robert I. Blum, President and Chief Executive Officer, is scheduled to present an overview of Cytokinetics' performance.

Comment?

Related Topix: Startups, Marketwire

Thu May 10, 2012

Rehab Management

Cytokinetics Participates In ALS Fundraising Events To Support ALS Awareness Month

In recognition of Amyotrophic Lateral Sclerosis Awareness Month, the San Francisco, Calif-based company Cytokinetics, Inc, announced that it has committed to several educational and support activities for ALS patients and their families.

Comment?

Related Topix: Startups

Wed May 09, 2012

Sys-Con Media

Cytokinetics Announces Company Participation and Support of ALS...

Cytokinetics, Incorporated announced today that, in connection with Amyotrophic Lateral Sclerosis Awareness Month, the company has committed to several educational and support activities for ALS patients and their families.

Comment?

Related Topix: Medicine, Als, Health, Startups

Fri Apr 27, 2012

BioSpace

Cytokinetics, Inc. Reports First Quarter 2012 Financial Results

Cytokinetics, Incorporated reported total research and development revenues of $1.8 million for the first quarter of 2012.

Comment?